BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2020
View Archived Issues
Converting catch and release to PARP traps
Read More
Novavax to initiate first-in-human studies of its new coronavirus candidate
Read More
Solnatide approved for compassionate use in Austria for treatment of severe COVID-19
Read More
Biophytis launches COVA clinical program of Sarconeos in COVID-19
Read More
Active compound of WP-1122 reduces coronavirus replication in vitro
Read More
Program to prevent the severe respiratory effects of COVID-19 using LAMELLASOME technology
Read More
Ariagen patents prodrugs for cancer
Read More
Clinical trial application for ACN-00177 approved in the U.K.
Read More
Thomas Jefferson University develops COVID-19 vaccine candidate
Read More
Cardurion Pharmaceuticals presents CAMK2 inhibitors
Read More
MediciNova to initiate clinical trial of ibudilast for COVID-19 ARDS
Read More
Enanta Pharmaceuticals identifies compounds for HBV infection
Read More
Discovery of a novel antimalarial compound, CHMFL-PI4K-127
Read More
Butantan-DV demonstrates safety and immunogenicity in phase II study
Read More
Jnana Therapeutics describes new compounds targeting mutant mammalian proteins
Read More
Focusing on commonalities to fight projected most common cause of death
Read More
New t-PA, u-PA and plasmin inhibitors presented by Alxerion Biotech
Read More
OncoImmune cleared to begin phase III study of CD24Fc for hospitalized patients with COVID-19
Read More
FDA approves Braftovi for metastatic colorectal cancer with BRAF V600E mutation
Read More
Sirnaomics reports phase II interim data on STP-705 for cutaneous squamous cell carcinoma in situ
Read More
Aivita offers updated survival data from phase II trial of AV-GBM-1 in glioblastoma
Read More
L-Leucine predicts lower mortality in patients with heart failure and preserved ejection fraction
Read More
CSL Behring and SAB partner on development of COVID-19 therapeutic candidate SAB-185
Read More